Bruce J. Kinon

10.6k total citations · 1 hit paper
153 papers, 7.4k citations indexed

About

Bruce J. Kinon is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Bruce J. Kinon has authored 153 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Psychiatry and Mental health, 22 papers in Pharmacology and 21 papers in Clinical Psychology. Recurrent topics in Bruce J. Kinon's work include Schizophrenia research and treatment (121 papers), Bipolar Disorder and Treatment (39 papers) and Treatment of Major Depression (22 papers). Bruce J. Kinon is often cited by papers focused on Schizophrenia research and treatment (121 papers), Bipolar Disorder and Treatment (39 papers) and Treatment of Major Depression (22 papers). Bruce J. Kinon collaborates with scholars based in United States, United Kingdom and Denmark. Bruce J. Kinon's co-authors include J. A. Gilmore, Jeffrey A. Lieberman, Haya Ascher‐Svanum, Virginia L. Stauffer, Bruce R. Basson, John M. Kane, Gary D. Tollefson, Sara Kollack‐Walker, Uriel Halbreich and Hong Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Bruce J. Kinon

153 papers receiving 7.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

1994 474 citations Bruce J. Kinon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce J. Kinon United States	47	5.0k	1.3k	1.1k	882	871	153	7.4k
Miquel Bernardo Spain	49	5.5k 1.1×	745 0.6×	1.5k 1.4×	1.7k 2.0×	740 0.8×	406	8.8k
William H. Carson United States	52	7.0k 1.4×	689 0.5×	1.5k 1.3×	1.1k 1.3×	464 0.5×	141	8.8k
Miranda Chakos United States	35	6.1k 1.2×	941 0.7×	1.7k 1.5×	1.4k 1.6×	503 0.6×	62	7.7k
Robert D. McQuade United States	59	8.0k 1.6×	1.4k 1.1×	1.8k 1.6×	1.6k 1.8×	1.0k 1.2×	199	11.4k
Alan I. Green United States	42	3.4k 0.7×	1.5k 1.2×	1.5k 1.3×	1.8k 2.0×	599 0.7×	100	7.0k
Brian Sheitman United States	33	4.6k 0.9×	681 0.5×	1.7k 1.5×	682 0.8×	400 0.5×	87	6.0k
Gary D. Tollefson United States	54	8.4k 1.7×	1.5k 1.2×	1.9k 1.7×	872 1.0×	918 1.1×	163	12.3k
Myrto Samara Germany	25	4.0k 0.8×	462 0.4×	969 0.9×	763 0.9×	477 0.5×	80	5.9k
Charles M. Beasley United States	48	5.8k 1.2×	754 0.6×	1.4k 1.3×	398 0.5×	463 0.5×	145	8.1k
Antony Loebel United States	41	5.3k 1.1×	670 0.5×	1.1k 1.0×	639 0.7×	445 0.5×	226	6.4k

Countries citing papers authored by Bruce J. Kinon

Since Specialization

Citations

This map shows the geographic impact of Bruce J. Kinon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce J. Kinon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce J. Kinon more than expected).

Fields of papers citing papers by Bruce J. Kinon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce J. Kinon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce J. Kinon. The network helps show where Bruce J. Kinon may publish in the future.

Co-authorship network of co-authors of Bruce J. Kinon

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce J. Kinon. A scholar is included among the top collaborators of Bruce J. Kinon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce J. Kinon. Bruce J. Kinon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Freitas, Daniela Fonseca de, Deborah Agbedjro, Giouliana Kadra-Scalzo, et al.. (2022). Clinical correlates of early onset antipsychotic treatment resistance. Journal of Psychopharmacology. 36(11). 1226–1233. 4 indexed citations

Kadra-Scalzo, Giouliana, Daniela Fonseca de Freitas, Deborah Agbedjro, et al.. (2022). A predictor model of treatment resistance in schizophrenia using data from electronic health records. PLoS ONE. 17(9). e0274864–e0274864. 7 indexed citations

Freitas, Daniela Fonseca de, Giouliana Kadra-Scalzo, Deborah Agbedjro, et al.. (2022). Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine. Journal of Psychopharmacology. 36(4). 498–506. 5 indexed citations

Axelsen, M., Nikolaj Bak, Lars Arvastson, et al.. (2020). A machine-learning framework for robust and reliable prediction of short- and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on multimodal neuropsychiatric data. Translational Psychiatry. 10(1). 276–276. 32 indexed citations

Nisenbaum, Laura, Fangyi Zhao, Brian A. Millen, et al.. (2016). Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia. Journal of Personalized Medicine. 6(1). 9–9. 14 indexed citations

Rabinowitz, Jonathan, Nomi Werbeloff, Ivo Caers, et al.. (2013). Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences. Schizophrenia Research. 150(2-3). 334–338. 65 indexed citations

Kinon, Bruce J., Hong Liu‐Seifert, Virginia L. Stauffer, & Jayanthi Jacob. (2013). Bone Loss Associated with Hyperprolactinemia in Patients with Schizophrenia. Clinical Schizophrenia & Related Psychoses. 7(3). 115–123. 32 indexed citations

Stauffer, Virginia L., Bruce J. Kinon, Haya Ascher‐Svanum, et al.. (2011). Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms. Schizophrenia Research. 134(2-3). 195–201. 34 indexed citations

Munsie, Leanne, Mike Reed, Cara Ruble, et al.. (2010). Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophrenia. The Pharmacogenomics Journal. 12(3). 246–254. 34 indexed citations

10.

Stauffer, Virginia L., Michael Case, Bruce J. Kinon, et al.. (2010). Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. Psychiatry Research. 187(1-2). 42–48. 52 indexed citations

11.

Stauffer, Virginia L., et al.. (2009). Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis. BMC Psychiatry. 9(1). 12–12. 19 indexed citations

12.

Kinon, Bruce J., et al.. (2008). PREDICTING RESPONSE TO RISPERIDONE TREATMENT THROUGH IDENTIFICATION OF EARLY-ONSET OF ANTIPSYCHOTIC DRUG ACTION IN SCHIZOPHRENIA. Schizophrenia Research. 102(1-3). 256–257. 1 indexed citations

13.

Liu‐Seifert, Hong, David H. Adams, & Bruce J. Kinon. (2005). Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. BMC Medicine. 3(1). 21–21. 120 indexed citations

14.

Kinon, Bruce J., Hong Liu‐Seifert, Jonna Ahl, Saeeduddin Ahmed, & Robert W. Baker. (2004). Longitudinal Effect of Olanzapine on Fasting Serum Lipids: A Randomized, Prospective, 4‐Month Study. Annals of the New York Academy of Sciences. 1032(1). 295–296. 6 indexed citations

15.

Kinon, Bruce J., J. A. Gilmore, Hong Liu, & Uriel Halbreich. (2003). Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Psychoneuroendocrinology. 28. 55–68. 285 indexed citations

16.

Kinon, Bruce J., J. A. Gilmore, Hong Liu, & Uriel Halbreich. (2003). Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials. Psychoneuroendocrinology. 28. 69–82. 121 indexed citations

17.

Halbreich, Uriel, Bruce J. Kinon, J. A. Gilmore, & L Kahn. (2002). Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology. 28. 53–67. 193 indexed citations

18.

Kinon, Bruce J., et al.. (2001). Exploration of a dose-response relationship in schizophrenia with the novel antipsychotic drug olanzapine. European Neuropsychopharmacology. 11. S278–S278. 3 indexed citations

19.

Tollefson, G.D., et al.. (1999). Controlled, Double-Blind Investigation of the Clozapine Discontinuation Symptoms With Conversion to Either Olanzapine or Placebo. Journal of Clinical Psychopharmacology. 19(5). 435–443. 43 indexed citations

20.

Kinon, Bruce J.. (1998). The routine use of atypical antipsychotic agents: maintenance treatment.. PubMed. 59 Suppl 19. 18–22. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact